Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on fingerstick capillary blood are used to support the monitoring of patient oral anticoagulant therapy (OAT) with vitamin K antagonists. These agents include warfarin (Coumadin), phenprocoumon (Marcumar) and acenocoumarol (Sintrom, also sold as other brand names). 


A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing found physicians in academic medical centers (AMCs) prescribed fewer of the promoted drugs, and more non-promoted drugs in the same drug classes, following policy changes to restrict marketing activities at those medical centers. The analysis encompassed 16.1 million prescriptions; while the decline observed was modest in terms of percentage, proportionally small changes can represent thousands of prescriptions.

May 5, 2017 — DASpecialists LLC, a provider of data abstraction and support services for mandated or voluntary cardiovascular registries, and cardiovascular information system vendor Lumedx Corp. announced they are partnering to create solutions for cardiovascular data management for U.S. hospitals.

The partnership brings together DASpecialists’ expertise and experienced clinical nurse analysts for both the ACC NCDR and STS data registries with Lumedx’s unique suite of cardiology data analytics, integration and registry tools. 


May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist Device (HVAD) system to include an additional product code and instructions to exchange recalled products. The company originally recalled the VAD system in November 2016 recall due to issues with its controller and power connector issues. Additionally, Medtronic announced a new related recall for the HeartWare splice kit intended to repair the HVAD driveline because it may cause electrical issues or stop the pump.


Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that can be caused by open-heart surgery. The findings point to a new potential way to help these hearts recover more completely.

The U.S. House of Representatives on Thursday narrowly approved the American Health Care Act, the legislation designed by House Republican leadership and backed by President Donald Trump to replace the Affordable Care Act (ACA), also known as Obamacare.

Spok Inc. recently released the second part of the company's annual mobility in healthcare survey. Spok has been conducting this survey since 2011 to assess mobile workflow enablement trends in hospitals across the country. More than 300 U.S. healthcare professionals responded to this year’s questions about mobile strategy development, bring your own device (BYOD) policies, communications infrastructure and opportunities to improve mobile communications.

American Regent, a member of the Daiichi Sankyo Group, announced that the first patient has been enrolled into the phase 3 clinical trial, HEART-FID. This double-blind, multicenter, prospective, randomized, placebo-controlled study will assess the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of patients with heart failure, iron deficiency and a reduced ejection fraction.

Epsilon Imaging Inc. announced a research study using EchoInsight was presented at the American College of Cardiology (ACC) 2017 Annual Scientific Session and Expo conference from a team at Northwestern University.

May 3, 2017 — A new study published in The Anatomical Record finds that peripheral arteries, easily accessible by ultrasound, may be useful for assessing a patient’s risk for ischemic cardiovascular disease, thus becoming an important diagnostic tool.

Subscribe Now